Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -637.32 Million USD | 82.43% |
| 2022 | -3.62 Billion USD | -185.27% |
| 2021 | 4.25 Billion USD | 11.54% |
| 2020 | 3.81 Billion USD | 116.88% |
| 2019 | 1.75 Billion USD | 387.17% |
| 2018 | 360.99 Million USD | 214.62% |
| 2017 | 114.74 Million USD | 307.96% |
| 2016 | 28.12 Million USD | -75.13% |
| 2015 | 113.09 Million USD | 27.29% |
| 2014 | 88.84 Million USD | 14.21% |
| 2013 | 77.79 Million USD | -54.03% |
| 2012 | 169.23 Million USD | -5.04% |
| 2011 | 178.22 Million USD | -3.92% |
| 2010 | 185.49 Million USD | 28.26% |
| 2009 | 144.62 Million USD | 61.57% |
| 2008 | 89.51 Million USD | -3.75% |
| 2007 | 92.99 Million USD | -9.94% |
| 2006 | 103.26 Million USD | 26.62% |
| 2005 | 81.55 Million USD | 19.51% |
| 2004 | 68.24 Million USD | -10.41% |
| 2003 | 76.17 Million USD | 12.24% |
| 2002 | 67.86 Million USD | 53.61% |
| 2001 | 44.17 Million USD | 42.05% |
| 2000 | 31.1 Million USD | 165.81% |
| 1999 | 11.7 Million USD | -51.85% |
| 1998 | 24.3 Million USD | 48.17% |
| 1997 | 16.4 Million USD | -37.4% |
| 1996 | 26.2 Million USD | 3.97% |
| 1995 | 25.2 Million USD | 61.54% |
| 1994 | 15.6 Million USD | 457.14% |
| 1993 | 2.8 Million USD | -82.05% |
| 1992 | 15.6 Million USD | 90.24% |
| 1991 | 8.2 Million USD | -23.36% |
| 1990 | 10.7 Million USD | 5.94% |
| 1989 | 10.1 Million USD | 6.32% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 383.91 Million USD | 9.78% |
| 2024 Q3 | 653.17 Million USD | 130.16% |
| 2024 Q2 | -2.16 Billion USD | -664.05% |
| 2023 Q3 | 106.25 Million USD | 109.14% |
| 2023 Q2 | -1.16 Billion USD | -1785.35% |
| 2023 FY | -637.32 Million USD | 82.43% |
| 2023 Q4 | 349.7 Million USD | 229.12% |
| 2023 Q1 | 68.96 Million USD | -91.73% |
| 2022 Q2 | -927.18 Million USD | 72.48% |
| 2022 Q1 | -3.36 Billion USD | -114.13% |
| 2022 FY | -3.62 Billion USD | -185.27% |
| 2022 Q4 | 833.49 Million USD | 607.51% |
| 2022 Q3 | -164.23 Million USD | 82.29% |
| 2021 FY | 4.25 Billion USD | 11.54% |
| 2021 Q1 | 977.41 Million USD | 16.48% |
| 2021 Q2 | 914.11 Million USD | -6.48% |
| 2021 Q3 | 3.92 Billion USD | 329.71% |
| 2021 Q4 | -1.57 Billion USD | -140.06% |
| 2020 Q4 | 839.1 Million USD | -36.18% |
| 2020 Q3 | 1.31 Billion USD | 36.05% |
| 2020 Q2 | 966.42 Million USD | 40.9% |
| 2020 Q1 | 685.91 Million USD | 23.93% |
| 2020 FY | 3.81 Billion USD | 116.88% |
| 2019 Q2 | 598.81 Million USD | -30.79% |
| 2019 Q4 | 553.48 Million USD | 313.85% |
| 2019 Q1 | 865.19 Million USD | 203.85% |
| 2019 Q3 | -258.81 Million USD | -143.22% |
| 2019 FY | 1.75 Billion USD | 387.17% |
| 2018 Q3 | 269.32 Million USD | 0.48% |
| 2018 Q4 | -833.14 Million USD | -409.35% |
| 2018 FY | 360.99 Million USD | 214.62% |
| 2018 Q1 | 656.77 Million USD | 839.6% |
| 2018 Q2 | 268.04 Million USD | -59.19% |
| 2017 Q3 | 27.39 Million USD | 444.05% |
| 2017 Q4 | 69.89 Million USD | 155.17% |
| 2017 Q1 | 12.41 Million USD | 160.35% |
| 2017 FY | 114.74 Million USD | 307.96% |
| 2017 Q2 | 5.03 Million USD | -59.44% |
| 2016 Q4 | -20.57 Million USD | -211.76% |
| 2016 FY | 28.12 Million USD | -75.13% |
| 2016 Q2 | 18.01 Million USD | 46.74% |
| 2016 Q1 | 12.27 Million USD | -75.19% |
| 2016 Q3 | 18.4 Million USD | 2.17% |
| 2015 FY | 113.09 Million USD | 27.29% |
| 2015 Q2 | 28.42 Million USD | 59.52% |
| 2015 Q3 | 17.37 Million USD | -38.89% |
| 2015 Q4 | 49.48 Million USD | 184.87% |
| 2015 Q1 | 17.81 Million USD | -54.36% |
| 2014 FY | 88.84 Million USD | 14.21% |
| 2014 Q4 | 39.03 Million USD | 239.19% |
| 2014 Q2 | 31.63 Million USD | 374.37% |
| 2014 Q1 | 6.66 Million USD | -77.87% |
| 2014 Q3 | 11.5 Million USD | -63.61% |
| 2013 Q1 | 19.49 Million USD | -58.95% |
| 2013 Q2 | 34.67 Million USD | 77.82% |
| 2013 Q3 | -7.09 Million USD | -120.47% |
| 2013 FY | 77.79 Million USD | -54.03% |
| 2013 Q4 | 30.13 Million USD | 524.51% |
| 2012 FY | 169.23 Million USD | -5.04% |
| 2012 Q2 | 48.34 Million USD | 55.92% |
| 2012 Q1 | 31 Million USD | -47.66% |
| 2012 Q4 | 47.5 Million USD | 12.08% |
| 2012 Q3 | 42.38 Million USD | -12.33% |
| 2011 FY | 178.22 Million USD | -3.92% |
| 2011 Q3 | 45.89 Million USD | 14.6% |
| 2011 Q2 | 40.04 Million USD | 21.21% |
| 2011 Q4 | 59.23 Million USD | 29.07% |
| 2011 Q1 | 33.03 Million USD | -51.35% |
| 2010 FY | 185.49 Million USD | 28.26% |
| 2010 Q2 | 37.95 Million USD | 8.88% |
| 2010 Q1 | 34.86 Million USD | -7.93% |
| 2010 Q3 | 44.76 Million USD | 17.93% |
| 2010 Q4 | 67.9 Million USD | 51.7% |
| 2009 FY | 144.62 Million USD | 61.57% |
| 2009 Q4 | 37.86 Million USD | -1.72% |
| 2009 Q3 | 38.52 Million USD | 1.46% |
| 2009 Q2 | 37.96 Million USD | 25.46% |
| 2009 Q1 | 30.26 Million USD | 468.37% |
| 2008 Q3 | 27.83 Million USD | -35.87% |
| 2008 FY | 89.51 Million USD | -3.75% |
| 2008 Q4 | -8.21 Million USD | -129.52% |
| 2008 Q1 | 26.49 Million USD | 114.45% |
| 2008 Q2 | 43.39 Million USD | 63.8% |
| 2007 Q4 | 12.35 Million USD | -55.83% |
| 2007 Q2 | 25.67 Million USD | -4.91% |
| 2007 Q1 | 26.99 Million USD | 62.15% |
| 2007 FY | 92.99 Million USD | -9.94% |
| 2007 Q3 | 27.97 Million USD | 8.96% |
| 2006 Q4 | 16.64 Million USD | -28.08% |
| 2006 Q3 | 23.15 Million USD | -28.25% |
| 2006 Q2 | 32.26 Million USD | 3.42% |
| 2006 Q1 | 31.19 Million USD | 131.92% |
| 2006 FY | 103.26 Million USD | 26.62% |
| 2005 FY | 81.55 Million USD | 19.51% |
| 2005 Q4 | 13.45 Million USD | -17.06% |
| 2005 Q3 | 16.21 Million USD | -11.8% |
| 2005 Q2 | 18.38 Million USD | -45.1% |
| 2005 Q1 | 33.49 Million USD | 95.75% |
| 2004 Q2 | 22.86 Million USD | 4.03% |
| 2004 Q4 | 17.11 Million USD | 172.03% |
| 2004 Q3 | 6.29 Million USD | -72.49% |
| 2004 Q1 | 21.97 Million USD | 14.52% |
| 2004 FY | 68.24 Million USD | -10.41% |
| 2003 Q4 | 19.19 Million USD | 98.66% |
| 2003 Q3 | 9.66 Million USD | -53.9% |
| 2003 Q2 | 20.95 Million USD | -20.51% |
| 2003 Q1 | 26.36 Million USD | 62.33% |
| 2003 FY | 76.17 Million USD | 12.24% |
| 2002 FY | 67.86 Million USD | 53.61% |
| 2002 Q4 | 16.24 Million USD | -2.26% |
| 2002 Q3 | 16.61 Million USD | 2.37% |
| 2002 Q2 | 16.23 Million USD | -13.54% |
| 2002 Q1 | 18.77 Million USD | 10.42% |
| 2001 FY | 44.17 Million USD | 42.05% |
| 2001 Q4 | 17 Million USD | 141.27% |
| 2001 Q1 | 8.56 Million USD | -6.37% |
| 2001 Q3 | 7.04 Million USD | -39.05% |
| 2001 Q2 | 11.56 Million USD | 34.92% |
| 2000 Q1 | 2.95 Million USD | 126.38% |
| 2000 Q4 | 9.15 Million USD | -34.25% |
| 2000 Q3 | 13.91 Million USD | 174.32% |
| 2000 Q2 | 5.07 Million USD | 71.71% |
| 2000 FY | 31.1 Million USD | 165.81% |
| 1999 Q1 | 10.8 Million USD | 68.75% |
| 1999 Q3 | 4.3 Million USD | -45.57% |
| 1999 FY | 11.7 Million USD | -51.85% |
| 1999 Q4 | -11.2 Million USD | -360.47% |
| 1999 Q2 | 7.9 Million USD | -26.85% |
| 1998 Q2 | 7.2 Million USD | -18.18% |
| 1998 FY | 24.3 Million USD | 48.17% |
| 1998 Q4 | 6.4 Million USD | 236.84% |
| 1998 Q1 | 8.8 Million USD | 528.57% |
| 1998 Q3 | 1.9 Million USD | -73.61% |
| 1997 Q1 | 7.5 Million USD | 200.0% |
| 1997 FY | 16.4 Million USD | -37.4% |
| 1997 Q4 | 1.4 Million USD | -46.15% |
| 1997 Q3 | 2.6 Million USD | -46.94% |
| 1997 Q2 | 4.9 Million USD | -34.67% |
| 1996 Q2 | 7.5 Million USD | -21.05% |
| 1996 Q1 | 9.5 Million USD | 53.23% |
| 1996 FY | 26.2 Million USD | 3.97% |
| 1996 Q4 | 2.5 Million USD | -62.69% |
| 1996 Q3 | 6.7 Million USD | -10.67% |
| 1995 Q3 | 4.4 Million USD | -32.31% |
| 1995 Q2 | 6.5 Million USD | -19.75% |
| 1995 FY | 25.2 Million USD | 61.54% |
| 1995 Q1 | 8.1 Million USD | 92.86% |
| 1995 Q4 | 6.2 Million USD | 40.91% |
| 1994 FY | 15.6 Million USD | 457.14% |
| 1994 Q3 | 3.9 Million USD | 39.29% |
| 1994 Q2 | 2.8 Million USD | -40.43% |
| 1994 Q1 | 4.7 Million USD | 687.5% |
| 1994 Q4 | 4.2 Million USD | 7.69% |
| 1993 FY | 2.8 Million USD | -82.05% |
| 1993 Q1 | 3.2 Million USD | 128.57% |
| 1993 Q3 | 100 Thousand USD | -50.0% |
| 1993 Q4 | -800 Thousand USD | -900.0% |
| 1993 Q2 | 200 Thousand USD | -93.75% |
| 1992 FY | 15.6 Million USD | 90.24% |
| 1992 Q4 | 1.4 Million USD | -36.36% |
| 1992 Q3 | 2.2 Million USD | -74.12% |
| 1992 Q2 | 8.5 Million USD | 142.86% |
| 1992 Q1 | 3.5 Million USD | 133.33% |
| 1991 FY | 8.2 Million USD | -23.36% |
| 1991 Q3 | 1.7 Million USD | 21.43% |
| 1991 Q1 | 3.6 Million USD | 5.88% |
| 1991 Q2 | 1.4 Million USD | -61.11% |
| 1991 Q4 | 1.5 Million USD | -11.76% |
| 1990 Q3 | 1.6 Million USD | -23.81% |
| 1990 FY | 10.7 Million USD | 5.94% |
| 1990 Q1 | 3.6 Million USD | 28.57% |
| 1990 Q4 | 3.4 Million USD | 112.5% |
| 1990 Q2 | 2.1 Million USD | -41.67% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | 2.7 Million USD | 0.0% |
| 1989 Q3 | 1.4 Million USD | -48.15% |
| 1989 Q4 | 2.8 Million USD | 100.0% |
| 1989 FY | 10.1 Million USD | 6.32% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 111.136% |
| Allurion Technologies Inc. | -82.3 Million USD | -674.354% |
| Artivion, Inc. | -30.69 Million USD | -1976.65% |
| Avanos Medical, Inc. | -61.8 Million USD | -931.269% |
| Butterfly Network, Inc. | -133.69 Million USD | -376.682% |
| Butterfly Network, Inc. | -133.69 Million USD | -376.682% |
| Boston Scientific Corporation | 1.59 Billion USD | 140.008% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -4244.404% |
| CONMED Corporation | 64.45 Million USD | 1088.728% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 145.445% |
| Paragon 28, Inc. | -47.84 Million USD | -1232.171% |
| Glaukos Corporation | -134.66 Million USD | -373.28% |
| Globus Medical, Inc. | 122.87 Million USD | 618.685% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | -2912.925% |
| Integer Holdings Corporation | 90.65 Million USD | 803.06% |
| Medtronic plc | 3.67 Billion USD | 117.337% |
| Nevro Corp. | -92.21 Million USD | -591.143% |
| Owlet, Inc. | -32.9 Million USD | -1837.096% |
| Penumbra, Inc. | 90.95 Million USD | 800.71% |
| Vicarious Surgical Inc. | -71.07 Million USD | -796.743% |
| Smith & Nephew plc | 263 Million USD | 342.329% |
| Sonendo, Inc. | -60.91 Million USD | -946.183% |
| STERIS plc | 378.23 Million USD | 268.498% |
| Stryker Corporation | 3.16 Billion USD | 120.137% |
| Vapotherm, Inc. | -58.19 Million USD | -995.19% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 162.239% |